Tango Therapeutics's total assets for Q4 2024 were $316.49M, a decrease of -10.19% from the previous quarter. TNGX total liabilities were $116.97M for the fiscal quarter, a -5.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.